Loading…
Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells
DNAJC15 is a mitochondrial TIMM23-related co-chaperonin known for its role in regulating oxidative phosphorylation efficiency, oxidative stress response and lipid metabolism. Recently, it has been proposed that the loss of DNAJC15 correlates with cisplatin (CDDP)-resistance onset in ovarian cancer (...
Saved in:
Published in: | Open biology 2025-01, Vol.15 (1), p.240151 |
---|---|
Main Authors: | , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c3581-b11bf1434f614cc041de1188e5829f2c796add6447f782c28747ecb1800e23453 |
container_end_page | |
container_issue | 1 |
container_start_page | 240151 |
container_title | Open biology |
container_volume | 15 |
creator | Miglietta, Stefano Sollazzo, Manuela Gherardi, Iacopo Milioni, Sara Cavina, Beatrice Marchio, Lorena De Luise, Monica Coada, Camelia Alexandra Fiorillo, Marco Perrone, Anna Myriam Kurelac, Ivana Gasparre, Giuseppe Iommarini, Luisa Ghelli, Anna Maria Porcelli, Anna Maria |
description | DNAJC15 is a mitochondrial TIMM23-related co-chaperonin known for its role in regulating oxidative phosphorylation efficiency, oxidative stress response and lipid metabolism. Recently, it has been proposed that the loss of DNAJC15 correlates with cisplatin (CDDP)-resistance onset in ovarian cancer (OC), suggesting this protein as a potential prognostic factor during OC progression. However, the molecular mechanisms through which DNAJC15 contributes to CDDP response remains poorly investigated. Here, we show that high levels of DNAJC15 are associated with accumulation of lipid droplets, decreased tumorigenic features and increased sensitivity to CDDP in OC cells. When overexpressed, DNAJC15 induced a phenotype displaying increased lipid peroxidation and subsequent ferroptosis induction. To prove a role for DNAJC15-induced ferroptosis in promoting sensitivity to CDDP, we reduced lipid peroxidation upon Ferrostatin 1 treatment, which decreased cells' vulnerability to ferroptosis ultimately recovering their CDDP-resistant phenotype. In conclusion, our study uncovers the role of DNAJC15 in modulating ferroptosis activation and in the onset of CDDP resistance in OC cells. |
doi_str_mv | 10.1098/rsob.240151 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_2b62dcd5d27349ac8dedddd4a1d00433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_2b62dcd5d27349ac8dedddd4a1d00433</doaj_id><sourcerecordid>3155719683</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3581-b11bf1434f614cc041de1188e5829f2c796add6447f782c28747ecb1800e23453</originalsourceid><addsrcrecordid>eNpVkU1vFDEMhkcIRKvSE3eUIxLaEieZmeSEquWrqMAFzlEm8XRTzcRLkl2p_55ZtlStL7Hj14-jvE3zGvgFcKPf50LDhVAcWnjWnAquupVQCp4_yk-a81Ju-RJtB0bBy-ZEGs2NFHDazN9jJb-hFHJ0E_Mbt8VMKSb28cfltzW0bJtppoqF7XdTwuyGOMV6xyqxEXOmbaUSC6NxmcWZMi5Vdaky2rsFmZh3yWNmHqepvGpejG4qeH5_njW_P3_6tf66uv755Wp9eb3ystWwGgCGEZRUYwfKe64gIIDW2GphRuF707kQOqX6sdfCC92rHv0AmnMUUrXyrLk6cgO5W7vNcXb5zpKL9t8F5Rvrco1-QiuGTgQf2iB6qYzzOmBYQjkInCspF9aHI2u7G2YMHlPNbnoCfdpJcWNvaG8BeimkMQvh7T0h058dlmrnWA7_4RLSrlgJbduD6fRh2buj1GcqJeP4sAe4PRhuD4bbo-GL-s3jpz1o_9sr_wJYI6iz</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3155719683</pqid></control><display><type>article</type><title>Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells</title><source>PubMed (Medline)</source><source>Publicly Available Content (ProQuest)</source><source>Royal Society Open Access Journals</source><creator>Miglietta, Stefano ; Sollazzo, Manuela ; Gherardi, Iacopo ; Milioni, Sara ; Cavina, Beatrice ; Marchio, Lorena ; De Luise, Monica ; Coada, Camelia Alexandra ; Fiorillo, Marco ; Perrone, Anna Myriam ; Kurelac, Ivana ; Gasparre, Giuseppe ; Iommarini, Luisa ; Ghelli, Anna Maria ; Porcelli, Anna Maria</creator><creatorcontrib>Miglietta, Stefano ; Sollazzo, Manuela ; Gherardi, Iacopo ; Milioni, Sara ; Cavina, Beatrice ; Marchio, Lorena ; De Luise, Monica ; Coada, Camelia Alexandra ; Fiorillo, Marco ; Perrone, Anna Myriam ; Kurelac, Ivana ; Gasparre, Giuseppe ; Iommarini, Luisa ; Ghelli, Anna Maria ; Porcelli, Anna Maria</creatorcontrib><description>DNAJC15 is a mitochondrial TIMM23-related co-chaperonin known for its role in regulating oxidative phosphorylation efficiency, oxidative stress response and lipid metabolism. Recently, it has been proposed that the loss of DNAJC15 correlates with cisplatin (CDDP)-resistance onset in ovarian cancer (OC), suggesting this protein as a potential prognostic factor during OC progression. However, the molecular mechanisms through which DNAJC15 contributes to CDDP response remains poorly investigated. Here, we show that high levels of DNAJC15 are associated with accumulation of lipid droplets, decreased tumorigenic features and increased sensitivity to CDDP in OC cells. When overexpressed, DNAJC15 induced a phenotype displaying increased lipid peroxidation and subsequent ferroptosis induction. To prove a role for DNAJC15-induced ferroptosis in promoting sensitivity to CDDP, we reduced lipid peroxidation upon Ferrostatin 1 treatment, which decreased cells' vulnerability to ferroptosis ultimately recovering their CDDP-resistant phenotype. In conclusion, our study uncovers the role of DNAJC15 in modulating ferroptosis activation and in the onset of CDDP resistance in OC cells.</description><identifier>ISSN: 2046-2441</identifier><identifier>EISSN: 2046-2441</identifier><identifier>DOI: 10.1098/rsob.240151</identifier><identifier>PMID: 39809321</identifier><language>eng</language><publisher>England: The Royal Society</publisher><subject>Animals ; Antineoplastic Agents - pharmacology ; Cell Line, Tumor ; Cisplatin - pharmacology ; cisplatin resistance ; DNAJC15 ; Drug Resistance, Neoplasm ; Female ; ferroptosis ; Ferroptosis - drug effects ; Gene Expression Regulation, Neoplastic ; HSP40 Heat-Shock Proteins - genetics ; HSP40 Heat-Shock Proteins - metabolism ; Humans ; Lipid Peroxidation - drug effects ; Mice ; mitochondria ; Mitochondria - drug effects ; Mitochondria - metabolism ; Mitochondrial Proteins - genetics ; Mitochondrial Proteins - metabolism ; ovarian cancer ; Ovarian Neoplasms - drug therapy ; Ovarian Neoplasms - genetics ; Ovarian Neoplasms - metabolism ; Ovarian Neoplasms - pathology</subject><ispartof>Open biology, 2025-01, Vol.15 (1), p.240151</ispartof><rights>2025 The Authors. 2025</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3581-b11bf1434f614cc041de1188e5829f2c796add6447f782c28747ecb1800e23453</cites><orcidid>0000-0001-8362-6639 ; 0000-0002-7755-2028 ; 0000-0001-5451-0063 ; 0000-0002-6209-0692 ; 0000-0002-3486-3985 ; 0000-0003-3140-4772 ; 0000-0001-8100-924X ; 0000-0003-0830-0000 ; 0000-0002-8364-9985 ; 0000-0002-6804-7302 ; 0000-0003-1229-9006 ; 0000-0001-5485-5360</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732399/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732399/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,3309,27901,27902,36990,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39809321$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Miglietta, Stefano</creatorcontrib><creatorcontrib>Sollazzo, Manuela</creatorcontrib><creatorcontrib>Gherardi, Iacopo</creatorcontrib><creatorcontrib>Milioni, Sara</creatorcontrib><creatorcontrib>Cavina, Beatrice</creatorcontrib><creatorcontrib>Marchio, Lorena</creatorcontrib><creatorcontrib>De Luise, Monica</creatorcontrib><creatorcontrib>Coada, Camelia Alexandra</creatorcontrib><creatorcontrib>Fiorillo, Marco</creatorcontrib><creatorcontrib>Perrone, Anna Myriam</creatorcontrib><creatorcontrib>Kurelac, Ivana</creatorcontrib><creatorcontrib>Gasparre, Giuseppe</creatorcontrib><creatorcontrib>Iommarini, Luisa</creatorcontrib><creatorcontrib>Ghelli, Anna Maria</creatorcontrib><creatorcontrib>Porcelli, Anna Maria</creatorcontrib><title>Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells</title><title>Open biology</title><addtitle>Open Biol</addtitle><description>DNAJC15 is a mitochondrial TIMM23-related co-chaperonin known for its role in regulating oxidative phosphorylation efficiency, oxidative stress response and lipid metabolism. Recently, it has been proposed that the loss of DNAJC15 correlates with cisplatin (CDDP)-resistance onset in ovarian cancer (OC), suggesting this protein as a potential prognostic factor during OC progression. However, the molecular mechanisms through which DNAJC15 contributes to CDDP response remains poorly investigated. Here, we show that high levels of DNAJC15 are associated with accumulation of lipid droplets, decreased tumorigenic features and increased sensitivity to CDDP in OC cells. When overexpressed, DNAJC15 induced a phenotype displaying increased lipid peroxidation and subsequent ferroptosis induction. To prove a role for DNAJC15-induced ferroptosis in promoting sensitivity to CDDP, we reduced lipid peroxidation upon Ferrostatin 1 treatment, which decreased cells' vulnerability to ferroptosis ultimately recovering their CDDP-resistant phenotype. In conclusion, our study uncovers the role of DNAJC15 in modulating ferroptosis activation and in the onset of CDDP resistance in OC cells.</description><subject>Animals</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Cell Line, Tumor</subject><subject>Cisplatin - pharmacology</subject><subject>cisplatin resistance</subject><subject>DNAJC15</subject><subject>Drug Resistance, Neoplasm</subject><subject>Female</subject><subject>ferroptosis</subject><subject>Ferroptosis - drug effects</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>HSP40 Heat-Shock Proteins - genetics</subject><subject>HSP40 Heat-Shock Proteins - metabolism</subject><subject>Humans</subject><subject>Lipid Peroxidation - drug effects</subject><subject>Mice</subject><subject>mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondrial Proteins - genetics</subject><subject>Mitochondrial Proteins - metabolism</subject><subject>ovarian cancer</subject><subject>Ovarian Neoplasms - drug therapy</subject><subject>Ovarian Neoplasms - genetics</subject><subject>Ovarian Neoplasms - metabolism</subject><subject>Ovarian Neoplasms - pathology</subject><issn>2046-2441</issn><issn>2046-2441</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkU1vFDEMhkcIRKvSE3eUIxLaEieZmeSEquWrqMAFzlEm8XRTzcRLkl2p_55ZtlStL7Hj14-jvE3zGvgFcKPf50LDhVAcWnjWnAquupVQCp4_yk-a81Ju-RJtB0bBy-ZEGs2NFHDazN9jJb-hFHJ0E_Mbt8VMKSb28cfltzW0bJtppoqF7XdTwuyGOMV6xyqxEXOmbaUSC6NxmcWZMi5Vdaky2rsFmZh3yWNmHqepvGpejG4qeH5_njW_P3_6tf66uv755Wp9eb3ystWwGgCGEZRUYwfKe64gIIDW2GphRuF707kQOqX6sdfCC92rHv0AmnMUUrXyrLk6cgO5W7vNcXb5zpKL9t8F5Rvrco1-QiuGTgQf2iB6qYzzOmBYQjkInCspF9aHI2u7G2YMHlPNbnoCfdpJcWNvaG8BeimkMQvh7T0h058dlmrnWA7_4RLSrlgJbduD6fRh2buj1GcqJeP4sAe4PRhuD4bbo-GL-s3jpz1o_9sr_wJYI6iz</recordid><startdate>202501</startdate><enddate>202501</enddate><creator>Miglietta, Stefano</creator><creator>Sollazzo, Manuela</creator><creator>Gherardi, Iacopo</creator><creator>Milioni, Sara</creator><creator>Cavina, Beatrice</creator><creator>Marchio, Lorena</creator><creator>De Luise, Monica</creator><creator>Coada, Camelia Alexandra</creator><creator>Fiorillo, Marco</creator><creator>Perrone, Anna Myriam</creator><creator>Kurelac, Ivana</creator><creator>Gasparre, Giuseppe</creator><creator>Iommarini, Luisa</creator><creator>Ghelli, Anna Maria</creator><creator>Porcelli, Anna Maria</creator><general>The Royal Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-8362-6639</orcidid><orcidid>https://orcid.org/0000-0002-7755-2028</orcidid><orcidid>https://orcid.org/0000-0001-5451-0063</orcidid><orcidid>https://orcid.org/0000-0002-6209-0692</orcidid><orcidid>https://orcid.org/0000-0002-3486-3985</orcidid><orcidid>https://orcid.org/0000-0003-3140-4772</orcidid><orcidid>https://orcid.org/0000-0001-8100-924X</orcidid><orcidid>https://orcid.org/0000-0003-0830-0000</orcidid><orcidid>https://orcid.org/0000-0002-8364-9985</orcidid><orcidid>https://orcid.org/0000-0002-6804-7302</orcidid><orcidid>https://orcid.org/0000-0003-1229-9006</orcidid><orcidid>https://orcid.org/0000-0001-5485-5360</orcidid></search><sort><creationdate>202501</creationdate><title>Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells</title><author>Miglietta, Stefano ; Sollazzo, Manuela ; Gherardi, Iacopo ; Milioni, Sara ; Cavina, Beatrice ; Marchio, Lorena ; De Luise, Monica ; Coada, Camelia Alexandra ; Fiorillo, Marco ; Perrone, Anna Myriam ; Kurelac, Ivana ; Gasparre, Giuseppe ; Iommarini, Luisa ; Ghelli, Anna Maria ; Porcelli, Anna Maria</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3581-b11bf1434f614cc041de1188e5829f2c796add6447f782c28747ecb1800e23453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Cell Line, Tumor</topic><topic>Cisplatin - pharmacology</topic><topic>cisplatin resistance</topic><topic>DNAJC15</topic><topic>Drug Resistance, Neoplasm</topic><topic>Female</topic><topic>ferroptosis</topic><topic>Ferroptosis - drug effects</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>HSP40 Heat-Shock Proteins - genetics</topic><topic>HSP40 Heat-Shock Proteins - metabolism</topic><topic>Humans</topic><topic>Lipid Peroxidation - drug effects</topic><topic>Mice</topic><topic>mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondrial Proteins - genetics</topic><topic>Mitochondrial Proteins - metabolism</topic><topic>ovarian cancer</topic><topic>Ovarian Neoplasms - drug therapy</topic><topic>Ovarian Neoplasms - genetics</topic><topic>Ovarian Neoplasms - metabolism</topic><topic>Ovarian Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Miglietta, Stefano</creatorcontrib><creatorcontrib>Sollazzo, Manuela</creatorcontrib><creatorcontrib>Gherardi, Iacopo</creatorcontrib><creatorcontrib>Milioni, Sara</creatorcontrib><creatorcontrib>Cavina, Beatrice</creatorcontrib><creatorcontrib>Marchio, Lorena</creatorcontrib><creatorcontrib>De Luise, Monica</creatorcontrib><creatorcontrib>Coada, Camelia Alexandra</creatorcontrib><creatorcontrib>Fiorillo, Marco</creatorcontrib><creatorcontrib>Perrone, Anna Myriam</creatorcontrib><creatorcontrib>Kurelac, Ivana</creatorcontrib><creatorcontrib>Gasparre, Giuseppe</creatorcontrib><creatorcontrib>Iommarini, Luisa</creatorcontrib><creatorcontrib>Ghelli, Anna Maria</creatorcontrib><creatorcontrib>Porcelli, Anna Maria</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Open biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Miglietta, Stefano</au><au>Sollazzo, Manuela</au><au>Gherardi, Iacopo</au><au>Milioni, Sara</au><au>Cavina, Beatrice</au><au>Marchio, Lorena</au><au>De Luise, Monica</au><au>Coada, Camelia Alexandra</au><au>Fiorillo, Marco</au><au>Perrone, Anna Myriam</au><au>Kurelac, Ivana</au><au>Gasparre, Giuseppe</au><au>Iommarini, Luisa</au><au>Ghelli, Anna Maria</au><au>Porcelli, Anna Maria</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells</atitle><jtitle>Open biology</jtitle><addtitle>Open Biol</addtitle><date>2025-01</date><risdate>2025</risdate><volume>15</volume><issue>1</issue><spage>240151</spage><pages>240151-</pages><issn>2046-2441</issn><eissn>2046-2441</eissn><abstract>DNAJC15 is a mitochondrial TIMM23-related co-chaperonin known for its role in regulating oxidative phosphorylation efficiency, oxidative stress response and lipid metabolism. Recently, it has been proposed that the loss of DNAJC15 correlates with cisplatin (CDDP)-resistance onset in ovarian cancer (OC), suggesting this protein as a potential prognostic factor during OC progression. However, the molecular mechanisms through which DNAJC15 contributes to CDDP response remains poorly investigated. Here, we show that high levels of DNAJC15 are associated with accumulation of lipid droplets, decreased tumorigenic features and increased sensitivity to CDDP in OC cells. When overexpressed, DNAJC15 induced a phenotype displaying increased lipid peroxidation and subsequent ferroptosis induction. To prove a role for DNAJC15-induced ferroptosis in promoting sensitivity to CDDP, we reduced lipid peroxidation upon Ferrostatin 1 treatment, which decreased cells' vulnerability to ferroptosis ultimately recovering their CDDP-resistant phenotype. In conclusion, our study uncovers the role of DNAJC15 in modulating ferroptosis activation and in the onset of CDDP resistance in OC cells.</abstract><cop>England</cop><pub>The Royal Society</pub><pmid>39809321</pmid><doi>10.1098/rsob.240151</doi><orcidid>https://orcid.org/0000-0001-8362-6639</orcidid><orcidid>https://orcid.org/0000-0002-7755-2028</orcidid><orcidid>https://orcid.org/0000-0001-5451-0063</orcidid><orcidid>https://orcid.org/0000-0002-6209-0692</orcidid><orcidid>https://orcid.org/0000-0002-3486-3985</orcidid><orcidid>https://orcid.org/0000-0003-3140-4772</orcidid><orcidid>https://orcid.org/0000-0001-8100-924X</orcidid><orcidid>https://orcid.org/0000-0003-0830-0000</orcidid><orcidid>https://orcid.org/0000-0002-8364-9985</orcidid><orcidid>https://orcid.org/0000-0002-6804-7302</orcidid><orcidid>https://orcid.org/0000-0003-1229-9006</orcidid><orcidid>https://orcid.org/0000-0001-5485-5360</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2046-2441 |
ispartof | Open biology, 2025-01, Vol.15 (1), p.240151 |
issn | 2046-2441 2046-2441 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_2b62dcd5d27349ac8dedddd4a1d00433 |
source | PubMed (Medline); Publicly Available Content (ProQuest); Royal Society Open Access Journals |
subjects | Animals Antineoplastic Agents - pharmacology Cell Line, Tumor Cisplatin - pharmacology cisplatin resistance DNAJC15 Drug Resistance, Neoplasm Female ferroptosis Ferroptosis - drug effects Gene Expression Regulation, Neoplastic HSP40 Heat-Shock Proteins - genetics HSP40 Heat-Shock Proteins - metabolism Humans Lipid Peroxidation - drug effects Mice mitochondria Mitochondria - drug effects Mitochondria - metabolism Mitochondrial Proteins - genetics Mitochondrial Proteins - metabolism ovarian cancer Ovarian Neoplasms - drug therapy Ovarian Neoplasms - genetics Ovarian Neoplasms - metabolism Ovarian Neoplasms - pathology |
title | Mitochondrial chaperonin DNAJC15 promotes vulnerability to ferroptosis of chemoresistant ovarian cancer cells |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T03%3A09%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mitochondrial%20chaperonin%20DNAJC15%20promotes%20vulnerability%20to%20ferroptosis%20of%20chemoresistant%20ovarian%20cancer%20cells&rft.jtitle=Open%20biology&rft.au=Miglietta,%20Stefano&rft.date=2025-01&rft.volume=15&rft.issue=1&rft.spage=240151&rft.pages=240151-&rft.issn=2046-2441&rft.eissn=2046-2441&rft_id=info:doi/10.1098/rsob.240151&rft_dat=%3Cproquest_doaj_%3E3155719683%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3581-b11bf1434f614cc041de1188e5829f2c796add6447f782c28747ecb1800e23453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3155719683&rft_id=info:pmid/39809321&rfr_iscdi=true |